CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication

NCT07344506 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

942

Enrollment

OTHER

Sponsor class

Conditions

H. Pylori Gastrointestinal Disease
H.Pylori Infection
H.Pylori Eradication Rate

Interventions

DRUG: Arm 1: Dexlansoprazole + Levofloxacin-Based Triple Therapy
DRUG: Arm 2: Lansoprazole + Levofloxacin-Based Triple Therapy
DRUG: Arm 3: Vonoprazan + Levofloxacin-Based Triple Therapy

Sponsor

Dow University of Health Sciences